Back to top
more

Hypermarcas (HYPMY)

(Delayed Data from OTC)

$5.49 USD

5.49
1,670

-0.06 (-1.01%)

Updated Apr 26, 2024 09:43 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 252)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for HYPMY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Hypermarcas falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents -99,999 556 429 937 570
Receivables NA 595 489 357 410
Notes Receivable NA 0 0 0 0
Inventories NA 425 242 179 168
Other Current Assets NA 76 43 60 53
Total Current Assets NA 1,652 1,203 1,532 1,200
Net Property & Equipment NA 549 393 330 334
Investments & Advances NA 30 21 7 12
Other Non-Current Assets NA 1 0 0 0
Deferred Charges NA 117 66 38 7
Intangibles NA 2,149 1,852 1,241 1,251
Deposits & Other Assets NA 103 138 198 224
Total Assets NA 4,601 3,672 3,346 3,020
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable NA 13 7 5 2
Accounts Payable NA 82 112 106 119
Current Portion Long-Term Debt NA 432 105 90 28
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 15 13 14 12
Other Current Liabilities NA 470 278 295 241
Total Current Liabilities NA 1,012 514 510 402
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 40 14 9 23
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 1,430 1,261 980 328
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 55 61 55 60
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 2,538 1,850 1,554 813
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 867 830 869 1,127
Capital Surplus NA 239 232 246 322
Retained Earnings NA 1,020 808 0 831
Other Equity NA -45 -32 678 -65
Treasury Stock NA 17 15 0 9
Total Shareholder's Equity NA 2,064 1,822 1,793 2,207
Total Liabilities & Shareholder's Equity NA 4,601 3,672 3,346 3,020
Total Common Equity 0 2,064 1,822 1,793 2,207
Shares Outstanding NA 633.40 633.40 633.40 632.20
Book Value Per Share 0.00 3.26 2.88 2.83 3.49

Fiscal Year End for Hypermarcas falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 -99,999 455 433 210
Receivables NA NA 699 648 551
Notes Receivable NA NA 0 0 0
Inventories NA NA 452 465 461
Other Current Assets NA NA 54 70 108
Total Current Assets NA NA 1,659 1,616 1,329
Net Property & Equipment NA NA 676 632 581
Investments & Advances NA NA 31 19 29
Other Non-Current Assets NA NA 4 1 1
Deferred Charges NA NA 177 162 139
Intangibles NA NA 2,328 2,283 2,156
Deposits & Other Assets NA NA 95 97 100
Total Assets NA NA 4,971 4,810 4,335
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA NA 5 5 5
Accounts Payable NA NA 63 74 78
Current Portion Long-Term Debt NA NA 371 353 225
Current Portion Capital Leases NA NA 0 0 0
Accrued Expenses NA NA 0 0 0
Income Taxes Payable NA NA 21 19 17
Other Current Liabilities NA NA 417 376 353
Total Current Liabilities NA NA 878 826 678
Mortgages NA NA 0 0 0
Deferred Taxes/Income NA NA 41 46 44
Convertible Debt NA NA 0 0 0
Long-Term Debt NA NA 1,645 1,633 1,465
Non-Current Capital Leases NA NA 0 0 0
Other Non-Current Liabilities NA 72 71 65
Minority Interest (Liabilities) NA NA 0 0 0
Total Liabilities NA NA 2,636 2,576 2,252
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA NA 0 0 0
Common Stock (Par) NA NA 917 905 862
Capital Surplus NA NA 241 237 232
Retained Earnings NA NA 1,233 1,064 1,014
Other Equity NA NA -51 36 -20
Treasury Stock NA NA 6 7 6
Total Shareholder's Equity NA NA 2,335 2,234 2,082
Total Liabilities & Shareholder's Equity NA NA 4,971 4,810 4,335
Total Common Equity 0 0 2,335 2,234 2,082
Shares Outstanding NA NA NA NA NA
Book Value Per Share 0.00 0.00 -0.02 -0.02 -0.02